Princeton Univesity to offer its students meningitis vaccine not approved by US

This is a summary. To read the whole story subscribe to

PRINCETON, N.J. — Princeton University officials decided Monday to make available a meningitis vaccine that hasn’t been approved in the United States to stop the spread of the sometimes deadly disease on campus.

The university said doses of the vaccine for the type B meningococcal bacteria are to be available in December and February for all undergraduate students, graduate students who live in dorms and university employees who have sickle cell disease and other medical conditions that make them more susceptible to meningitis.

The university said the plan was recommended by the US Centers for Disease Control and Prevention. The vaccinations are to be paid for by the university and are not mandatory.

Full story for subscribers.

Get the full story with unlimited access to

Just 99 cents for four weeks.